The FDA approved pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa (Keytruda Qlex) in combination with ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug ...
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced ...
The FDA has approved two immunotherapy combination therapies for adults with muscle-invasive bladder cancer. Pembrolizumab ...
The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The ...
Deion Sanders reflected on Colorado's 3-9 season, his recovery from bladder cancer surgery and why he's focused on ...
Talking With Docs on MSN
Bladder cancer risk factors symptoms and treatment options
Bladder cancer risk factors symptoms and treatment options ...
Deion “Coach Prime” Sanders says he feels like his old — and younger — self again a year after undergoing surgery to remove ...
On Friday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s PFE and Astellas Pharma Inc.’s ALPMF ALPMY ...
Deion Sanders has accomplished a lot throughout his career, setting multiple milestones as a football and baseball player at ...
Bladder cancer continues to be one of the most frequently diagnosed malignancies worldwide, with current treatments such as surgery and chemotherapy often ...
The platinum-free combination significantly improved EFS, OS, and pathologic complete response rates compared with standard neoadjuvant gemcitabine/cisplatin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results